期刊文献+

人脐血间充质干细胞携带人肿瘤坏死因子α基因逆转绒癌耐药体外研究

In vitro study on reversing the drug resistance of choriocarcinoma cell line JEG-3/VP16 by the expression of adenovirus-mediated hTNFα gene in human umbilical cord blood-derived mesenchymal stem cells
原文传递
导出
摘要 目的观察人脐血间充质干细胞携带人肿瘤坏死因子α(TNF-α)基因对绒癌耐药细胞株耐药指数的影响。方法应用AdMax系统构建携带TNF-α基因的腺病毒载体。鉴定、分离、培养、扩增、纯化人脐血间充质干细胞(hUCB-MSCs)。携带TNF-α基因的重组腺病毒感染hUCB-MSCs后,与绒癌耐药细胞株JEG3/VP16共培养,空载腺病毒(Ad-EGFP)感染的hUBC-MSCs做为对照,MTT法测定共培养48h后JEG-3/VP16对依托泊苷(VP16)、氟尿嘧啶(5-FU)、甲氨蝶呤(MTX)耐药情况。结果(1)酶切、聚合酶链式反应(PCR)鉴定构建的重组腺病毒携带TNF-α基因。(2)重组腺病毒可高效感染hUCB-MSCs。(3)JEG-3/VP16和转染TNFa基因的hUCB-MSCs共培养,JEG-3/VP16对VP16、5-FU、MTX的IC50分别下降至未共培养前IC50的1/12.8,1/6.75和1/10.1。结论携带hTNFα基因的hUCB-MSCs与绒癌耐药细胞株JEG-3/VP16共培养后,逆转了JEG-3/VP16的耐药性。 Objective To construct the replication-deficient recombinant adenoviruses vectors contained human TNFα gene and to investigate TNFα expression in human umbilical cord blood-derived mesenchymal stem cells(hUCB-MSCs). And to observe the drug-resistance changes of JEG-3/VP16 after co-culture with hUCB-MSCs transfected with adenovirus-mediated hTNFα gene. Method Human TNF-α gene was amplified by PCR method from plasmid pCMV-SPORT6-TNF and cloned into shuttle vector pDC316-IRES-EGFP which was carried into 293 cells together with backbone plasmid pBHGlox_E1,3Cre by lipofectamine 2000 to obtain packed recombinant adenovirus Ad-TNFα. hUCB-MSCs were isolated,cultivated and identified in vitro. The resistance index of JEG-3/VP16 was determined by MTT test after co-culture with hUCB-MSCs transfected with hTNFα gene. Result (1)The packed recombinant adenovirus Ad-TNFα was identified using PCR and enzyme digestion.(2)The adenovirus vector was constructed successfully and high efficient expression of TNFα in hUCB-MSCs was detected. (3)MTT test showed that the resistance index of JEG-3/VP16 decreased after co-culture with hUCB-MSCs transfected huTNF-α gene. Conclusion The drug resistance of JEG-3/VP16 can be reversed after co cultured with hUCB-MSCs transfected with hTNFα gene.
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2010年第3期193-195,共3页 Chinese Journal of Practical Gynecology and Obstetrics
基金 高等学校博士学科点专项科研基金(NO.20040023028)
关键词 间充质干细胞 肿瘤坏死因子 腺病毒载体 耐药性 mesenchymal stem cells tumor necrosis factor recombinant adenovirus vector drug-resistance
  • 相关文献

参考文献7

  • 1Banqari DS, Mittal SK. Current strategies and future directions for eluding adenoviral vector immunity[J]. Curr Gene Thcr,2006,6 (2) :215-226.
  • 2Campos SK, Barry MA. Current advances and future challenges in Adenoviral vector biology and targeting [ J]. Curr Gene Ther, 2007,7 ( 3 ) : 189-204.
  • 3Edelstein ML, Abedi MR, Wixon J, et al. Gene therapy clinical trials worldwide 1989-2004-an overview[J]. J Gene Med,2004, 6(6) :597-602.
  • 4Chiocca EA, Abbed KM, Tatter S, et al. A phase 1 open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting[J]. Mot Ther, 2004,10 ( 5 ) : 958-966.
  • 5Nielsen LL, Gurnani M, Syed J. et al. Recombinant E1-deleted adenovirus-mediated gene therapy for cancer:efficacy studies with 1753 tumor suppressor gene and liver histology in tumor xenograft models [ J ]. Hum Gen Ther, 1998,9:681-694.
  • 6李志勇,刘磊,田卫东,陈希哲,阎征斌,林云锋.绿色荧光蛋白基因转染大鼠骨髓间充质干细胞的实验研究[J].中华口腔医学杂志,2005,40(2):150-153. 被引量:16
  • 7Sato H, Kuwashima N, Sakaida T, et al. Epidermal growth fac tot receptor-transfected bone marrow stromal cells exhibit en hanced migratory response and therapeutic potential against murine brain tumors[J]. Cancer Gene Ther, 2005,12:757-768.

二级参考文献9

  • 1La Russa VF, Schwarzenberger P, Miller A, et al. Marrow stem cells, mesenchymal progenitor cells, and stromal progeny. Cancer Invest, 2002, 20: 110-123.
  • 2Tosh D, Slack JM. How cells change their phenotype. Nat Rev Mol Cell Biol, 2002,3: 187-194.
  • 3Shayakhmetov DM. High-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells. J Virol, 2000, 76: 1135-1141.
  • 4Minguell JJ, Erices A, Conget P. Mesenchymal stem cells. Exp Biol Med(Maywood), 2001,226: 507-520.
  • 5Warnke PH, Springer IN, Wiltfang J, et al. Growth and transplantation of a custom vascularised bone graft in a man. Lancet, 2004,364: 766-770.
  • 6Ohazama A, Modino SA, Miletich I, et al. Stem-cell-based tissue engineering of murine teeth. J Dent Res, 2004,83:518-522.
  • 7Tsien RY. The green fluorescent protein. Annu Rev Biochem, 1998,67: 509-544.
  • 8Nielsen LL, Gurnani M, Syed J, et al. Recombinant E1-deleted adenovirus-mediated gene therapy for cancer: efficacy studies with p53 tumor suppressor gene and liver histology in tumor xenograft models. Hum Gen Ther, 1998, 9:681-694.
  • 9Preston SL, Alison MR, Forbes SJ, et al. The new stem cell biology: something for everyone. Mol Pathol, 2003,56:86-96.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部